FS Credit Income Fund Announces Distribution Rate Increase for June 2024
/PRNewswire/ -- FS Investments, a leading alternative asset manager with over $79 billion in assets under management, today announced that FS Credit Income...
Stay updated with breaking news from Performing Credit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- FS Investments, a leading alternative asset manager with over $79 billion in assets under management, today announced that FS Credit Income...
The MD and CIO of Avendus Wealth Management says HNIs have not been entering the SME space meaningfully because of bad experiences earlier
Piramal Alternatives invested Rs 110 crore in Noida-based Biodeal Pharmaceuticals through convertible instruments. The funding will enhance infrastructure, technology, and a nutraceuticals manufacturing facility. Biodeal is a key contract manufacturing player, specializing in nasal sprays and achieving PIC/S approval.
PRESS RELEASE Piramal Alternatives invests INR 110 Cr. in Biodeal Pharmaceuticals The strategic investment will fuel Biodeal's development...
"We have received very good response from domestic investors including HNIs, pension funds, and family offices and have raised close to ₹500 crore in a very short time," said Abhinav Jain, MD-Performing Credit at Edelweiss Alternatives.